Ami Mezezi, a genetics and biotechnology expert, co-founded his company, EvolveGene, in 2015. EvolveGene is built on over 25 years of expertise in the field of human reproductive medicine with a scientific team of world leading embryologists, geneticists and fertility experts. The EvolveGene mission is to bring a new perspective to fertility and reproductive care through accurate and advanced genetic screening.
Ami graduated with a Bachelors degree in Molecular Biology and Genetics from the University of Guelph in Ontario, Canada. He then went on to receive his Masters degree in Biomedical Research from Eastern Virginia Medical School in Norfolk, Virginia and a Masters degree in Physiology from Georgetown University in Washington, D.C. Through his experience with and knowledge of genetics and reproductive medicine, he c0-founded his ompany that has since proved successful. Headquartered in the US, EvolveGene has offices in Canada, Belgium and Hong Kong and over 90 distributors worldwide. Ami foresees continual growth as the company continues to develop new innovative products and genetic screens.
EvolveGene offers comprehensive preconception and prenatal screens during any reproductive stage. Through the latest, specialized technologies, such as Next Generation Sequencing and in-depth chromosomal analysis, EvolveGene delivers superior reproductive genetic screening. The company is also committed to advancing the fields of reproductive medicine, reproductive genetics and In-Vitro Fertilization through innovative research. EvolveGene is part of IRB approved research studies in the US and Canada in conjunction with their scientific team to achieve these goals.